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A
 
BSTRACT
Background:
 
Adhesion molecules participate in an
important part of inflammatory process in relation to
the accumulation of inflammatory cells, such as eosi-
nophils. The expression of adhesion molecules differs
depending upon the cells and tissue. In the present
study, to elucidate these differences, a comparative
study was performed on the prolongation of eosi-
nophil survival via adhesion molecules.
 
Methods:
 
Blood eosinophils were purified using
Percoll and anti-CD16 antibody coated magnetic
beads. Eosinophils were incubated with or without the
various concentrations of adhesion molecules for 18
or 36 h. Eosinophil survival was analyzed by a flow
cytometer with staining by annexin V (AV) and pro-
pidium iodide (PI).
 
Results:
 
Intercellular adhesion molecule (ICAM)-1,
fibronectin (FN) and cellular fibronectin (cFN), but not
vascular cell adhesion molecule (VCAM)-1, signifi-
cantly prolonged eosinophil survival compared with
control. The present comparative study for eosinophil
survival showed the following tendency: cFN = FN
> ICAM-1 > VCAM-1. Moreover, enhancement of
prolonged eosinophil survival by connecting segment-
1 was greater than that by FN and cFN.
 
Conclusions:
 
The regulation of adhesion molecules,
by not only preventing eosinophil adhesion but also
eosinophil activation, may be a potential target in the
treatment of allergic inflammatory disorders.
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I
 
NTRODUCTION
 
Inflammatory responses are now believed to play a
primary role in immunologic and allergic responses.
Eosinophils are considered to be a major type of
inflammatory cell, because they cause tissue damage
with their granular proteins and also modulate inflam-
mation by producing cytokines.
 
1
 
Adhesion molecules participate in an important part of
inflammatory process, including eosinophil migration
and accumulation into inflamed sites.
 
2
 
 Among the 
 
β
 
1
integrins, very late antigen (VLA)-4 binds vascular cell
adhesion molecule (VCAM)-1 and fibronectin (FN), and
the 
 
β
 
2 integrins Mac-1 and LFA-1 bind to intercellular
adhesion molecule (ICAM)-1, expressed on eosinophils.
These integrins have been considered to play a role in
cell activation as well as cell adhesion. Signals via adhe-
sion molecules augment the release of granular proteins,
the production of reactive oxygen species (ROS)
 
3–5
 
 and
eosinophil survival.
 
6,7
 
The expression of adhesion molecules differs depend-
ing upon the cells and tissue. For example, VCAM-1 is
mainly expressed on the surface of vascular endothelial
cells, ICAM-1 is expressed on respiratory epithelium
and vascular endothelial cells and FN is expressed in the
interstitium.
 
8
 
 However, differences among the effects of
various adhesion molecules on eosinophil survival have
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not been studied sufficiently. In the present study, to eluci-
date these differences, the survival of eosinophils cultured
with adhesion molecules was examined by flow cytometry
analysis. Moreover, a comparative study on the prolon-
gation of eosinophil survival via adhesion molecules was
performed.
 
M
 
ETHODS
 
Eosinophil preparation
 
Peripheral venous blood was obtained from subjects
with mild to moderate eosinophilia. Eosinophils were
isolated by sedimentation with 6% dextran followed by
centrifugation on 1.088 Percoll (Pharmacia, Uppsala,
Sweden) density gradients,
 
9
 
 as modified from the
method of Hansel 
 
et al
 
.
 
10
 
 Cells were further purified by
negative selection using anti-CD16 immunomagnetic
beads and a MACS system (Miltenyi Biotec, Bergisch
Gladbach, Germany). Eosinophils (>99% purity) were
then suspended in Hank’s balanced salt solution (HBSS)
with 1% fetal calf serum (FCS) in tubes coated with 3%
human serum albumin.
 
Eosinophil culture
 
A 48-well flat-bottom tissue culture-treated plate was
coated with recombinant soluble (rs) ICAM-1 (R&D
 
Fig. 1
 
Dot plots of FACScan analysis on the prolongation of eosinophil survival. This figure shows dot plots after cells had been
incubated with or without adhesion molecules for 18 h. Values in the figure denote the percentage of living cells (annexin V (AV)-
negative and propidium iodide (PI)-negative cells). VCAM-1, vascular cell adhesion molecule-1; ICAM-1, intercellular adhesion
molecule-1; FN, fibronectin; cFN, cellular fibronectin.
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Systems, Minneapolis, MN, USA), rs VCAM-1 (R&D
Systems), FN (Sigma-Aldrich, St Louis, MO, USA), cellu-
lar fibronectin (cFN; Sigma-Aldrich) and connecting
segment-1 (CS-1; Sigma-Aldrich) at 37
 
°
 
C for 1 h. Block-
ing was then performed with 1% bovine serum albumin
(BSA). Eosinophils were suspended in RPMI 1640 (Nissui
Pharmaceutical, Tokyo, Japan) containing 3% FCS at a
concentration of 1 
 
×
 
 10
 
6
 
 /mL for culture in a 5% CO
 
2
 
atmosphere at 37
 
°
 
C. The plate was coated with 1% BSA
as a control.
 
Assay for eosinophil survival
 
Eosinophils were washed twice in cold phosphate-buff-
ered saline (PBS) after incubation with or without various
concentrations of adhesion molecules (0.1, 1, 10 and
50 
 
µ
 
g/mL) for 18 or 36 h. Then, double staining with
propidium iodide (PI) and annexin V (AV) (Apoptosis
Detection Kit; MBL, Nagoya, Japan) and FACScan assay
(Becton-Dickinson, San Jose, CA, USA) were per-
formed.
 
11
 
 The percentage of viable cells was given by
the percentage of double-negative cells depicted in the
lower left quadrant.
 
Statistical analysis
 
Results are expressed as the mean 
 
±
 
 SEM. An 
 
ANOVA
 
 was
used for group analysis. For Fisher’s multiple compari-
son test, 
 
P
 
 < 0.05 was considered significant.
 
R
 
ESULTS
 
Effects of adhesion molecules on eosinophil 
survival
 
Eosinophils were cultured with or without 10 
 
µ
 
g/mL
ICAM-1, VCAM-1, FN or cFN for 18 h. The percentage
of viable cells was then determined using a flow cyto-
meter, after eosinophils were double stained with AV
and PI (Fig. 1). Intercellular adhesion molecule-1
(56.9 
 
±
 
 8.8%; 
 
P
 
 < 0.05), FN (63.8 
 
±
 
 11.2%; 
 
P
 
 < 0.01)
and cFN (64.6 
 
± 
 
5.3%; 
 
P
 
 < 0.01), but not VCAM-1
(42.9 
 
±
 
 2.6%; 
 
P
 
 > 0.05), significantly prolonged eosi-
nophil survival compared with control (38.6 
 
±
 
 6.0%;
Fig. 2). With regard to the number of apoptotic cells,
indicated by the percentage of AV-positive and PI-
negative cells, there were no significant differences
among groups cultured with various adhesion molecules
(data not shown). The percentage of viable cells after
36 h was also examined, but no significant differences
were observed (Table 1).
 
Effect of various concentrations of adhesion 
molecules on eosinophil survival
 
To investigate the effect of various concentrations of
adhesion molecules on eosinophil survival, eosinophils
were cultured with adhesion molecules at concentrations
of 0.1, 1, 10 and 50 
 
µ
 
g/mL for 18 h on the basis of
 
Table 1
 
Effects of adhesion molecules on prolongation of
eosinophil survival
Survival rate (%)
 
P
 
Control 47.70 
 
± 
 
5.74
VCAM-1 46.41 
 
± 
 
5.55 0.443
Fibronectin 48.90 
 
± 
 
6.42 0.562
Cellular fibronectin 52.88 
 
± 
 
5.27 0.592
ICAM-1 51.62 
 
± 
 
2.43 0.433
 
Data are the mean 
 
± 
 
SEM (
 
n
 
 = 3–5). Fisher’s multiple comparison
test was used for 
 
P
 
 values.
Eosinophils were cultured with or without 10 
 
µ
 
g/mL adhesion
molecules for 36 h and their effects were compared with control.
VCAM-1, vascular cell adhesion molecule-1; ICAM-1, intercellular
adhesion molecule-1.
 
Fig. 2
 
Effects of adhesion molecules on the prolongation of
eosinophil survival. Eosinophils were cultured with or without
10 
 
µ
 
g/mL adhesion molecules for 18 h and their effects were
compared with control. Data are expressed as the mean 
 
±
 
 SEM
(
 
n
 
 = 3–5). *
 
P
 
 < 0.05, **
 
P
 
 < 0.01 compared with control
(Fisher’s multiple comparison test). AV(–)PI(–) cells, annexin
V-negative and propidium iodide-negative cells; VCAM-1, vas-
cular cell adhesion molecule-1; ICAM-1, intercellular adhesion
molecule-1; FN, fibronectin; cFN, cellular fibronectin.
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results described above (Fig. 3). Fibronectin and cFN
prolonged eosinophil survival, with the peak effect
at  concentrations of 10 
 
µ
 
g/mL FN (63.8 
 
±
 
 11.3%;
 
P
 
 < 0.01) and 50 
 
µ
 
g/mL cFN (68.4 
 
±
 
 4.9%; 
 
P
 
 < 0.01).
Intercellular adhesion molecule-1 showed the highest
prolongation of eosinophil survival at 10 
 
µ
 
g/mL
(56.9 
 
± 
 
8.8%; 
 
P
 
 < 0.05). Regarding the effect of
VCAM-1 on prolonged eosinophil survival, no signifi-
cant differences were observed with any concentration
used.
 
Effect of the CS-1 region on eosinophil 
survival
 
To elucidate the effect of the CS-1 region on eosinophil
survival, a comparative study between CS-1, FN and
cFN was performed using concentrations of 1 
 
µ
 
g/mL
(Fig. 4). At 1 
 
µ
 
g/mL, CS-1 significantly prolonged eosi-
nophil survival (71.3 
 
±
 
 5.2%; 
 
P
 
 < 0.01) compared with
control.
 
D
 
ISCUSSION
 
In the present study, it was demonstrated that ligands of
both 
 
β
 
1 and 
 
β
 
2 integrins prolonged eosinophil survival.
We have reported previously that prolonged survival of
eosinophils induced by ICAM-1 was completely blocked
by anti-granulocyte–macrophage colony stimulating
factor (GM-CSF)
 
6
 
 and FN also prolonged eosinophil
survival, which was related to the production of GM-CSF
and interleukin (IL)-3.
 
12
 
 Thus, these reports suggested
that GM-CSF and other cytokines may be produced
by eosinophils themselves in response to signals by
adhesion molecules. Further investigations should clarify
whether cytokines may be produced to prolong eosi-
nophil survival.
Furthermore, the present comparative study on
eosinophil survival showed the following tendency:
cFN = FN > ICAM-1 > VCAM-1. Iintercellular adhe-
sion molecule-1 and VCAM-1 are mainly expressed
in vascular endothelium, whereas FN and cFN are
expressed in the interstitium.
 
8
 
 In this regard, this tendency
may reflect a pathophysiologic process during activation
of eosinophils at the site of inflammation. Moreover,
Wu 
 
et al
 
. have reported that VCAM-1 robustly adheres to
 
Fig. 3
 
Effect of various concentrations of adhesion molecules
on eosinophil survival. Eosinophils were incubated with or with-
out 0.1, 1, 10 and 50 
 
µ
 
g/mL adhesion molecules for 18 h. The
percentages of viable cells were compared with control. Data
are expressed as the mean 
 
±
 
 SEM (
 
n
 
 = 4). *
 
P
 
 < 0.05,
**
 
P
 
 < 0.01 compared with control (Fisher’s multiple compari-
son test). (
 

 
), control; (
 

 
), intercellular adhesion molecule-1;
(
 

 
), vascular cell adhesion molecule-1; (
 

 
), fibronectin;
(
 

 
), cellular fibronectin.
 
Fig. 4
 
Effect of the connecting segment-1 (CS-1) region on
eosinophil survival. Eosinophils cultured with or without
1 
 
µ
 
g/mL of cellular fibronectin (cFN), fibronectin (FN) and
CS-1 for 18 h were compared with control. The percentages of
viable cells were compared with control. Data are expressed as
the mean 
 
±
 
 SEM (
 
n
 
 = 4). *
 
P < 0.05 compared with control
(Fisher’s multiple comparison test).
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VLA-4 more than FN.13 In addition to FN, Meerschaert
et al. have reported that eosinophil survival is prolonged
by VCAM-1.14 In the present study, FN prolonged eosi-
nophil survival more than VCAM-1. In addition, to
confirm this finding, the effect of the CS-1 region, which
is the binding site for FN, was investigated. The CS-1
region, as well as FN, prolonged eosinophil survival
more than VCAM-1. Taken together, these findings
suggest that the mechanism of cell activation, such as the
prolongation of eosinophil survival via adhesion mole-
cules, may be different from that of cell adherence.
We reported previously that eosinophils release eosi-
nophil cationic protein (ECP) and eosinophil-derived
neurotoxin (EDN) in response to signaling through the
adherence to ICAM-1.4 Reactive oxygen species, as well
as eosinophil granule proteins, from eosinophils are con-
sidered inflammatory mediators that cause tissue injury at
the inflamed site. In this context, we also reported pre-
viously the possible involvement of adhesion molecules in
ROS production from eosinophils.15 The present findings
suggest that adhesion molecules may promote tissue
damage by eosinophil adherence to the inflamed site
and prolongation of eosinophil survival. Symptomatic
improvement by the preventing migration and/or activa-
tion of eosinophils at the site of airway inflammation was
achieved in an animal model of asthma after treatment
with an anti-ICAM-1 monoclonal antibody (mAb) or anti-
VLA-4 mAb.16–18 Therefore, the regulation of adhesion
molecules, by not only preventing eosinophil adhesion
but also activation, such as prolongation of survival, may
be a potential target for the treatment of allergic inflam-
matory disorders.
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